Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms
Epigenetic control of enhancers may contribute to neurological disease. Here the authors carry out genome-wide analysis of DNA methylation in neurons isolated postmortem from patients with Alzheimer’s disease.
Guardado en:
Autores principales: | Peipei Li, Lee Marshall, Gabriel Oh, Jennifer L. Jakubowski, Daniel Groot, Yu He, Ting Wang, Arturas Petronis, Viviane Labrie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5670791e46748e5b81b102dfc4bd386 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis
por: Shraddha Pai, et al.
Publicado: (2019) -
Cytosine modifications exhibit circadian oscillations that are involved in epigenetic diversity and aging
por: Gabriel Oh, et al.
Publicado: (2018) -
Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer’s Disease Mouse Model
por: Jiuyang Ding, et al.
Publicado: (2021) -
Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer’s Disease
por: Sabyasachi Maity, et al.
Publicado: (2021) -
Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease
por: Jacob W. Vogel, et al.
Publicado: (2020)